200
Participants
Start Date
March 16, 2017
Primary Completion Date
February 19, 2020
Study Completion Date
February 10, 2021
Tocilizumab
Active drug: Tocilizumab, 20 mg/ml; 14 ml (280 mg) dissolved in 100 ml NaCl 0.9 % i.v. once.
Sodium chloride 0.9%
Placebo: Sodium chloride 0.9%; 100 ml i.v. once.
St. Olav Hospital, Trondheim
Oslo University Hospital, Rikshospitalet, Oslo
Oslo University Hospital, Ullevål, Oslo
St. Olavs Hospital
OTHER
South-Eastern Norway Regional Health Authority
OTHER
University of Oslo
OTHER
Norwegian University of Science and Technology
OTHER
Oslo University Hospital
OTHER